Results 151 to 160 of about 43,261 (257)

Conformal prediction quantifies wearable cuffless blood pressure with certainty

open access: yesScientific Reports
Though wearable cuffless blood pressure (BP) measurement technology has attracted significant attention from both academia and industry, the ability of existing methods and devices to track dynamic BP changes and provide reliable BP readings remains low,
Zhan Shen   +3 more
doaj   +1 more source

Improving stroke pathways using an adhesive ambulatory ECG patch: reducing time for patients to ECGs and subsequent results. [PDF]

open access: yesFuture Healthc J, 2022
Lang A   +14 more
europepmc   +1 more source

Ambulatory Heart Rate Variability Monitoring: Comparisons Between the Empatica E4 Wristband and Holter ECG

open access: green, 2021
Elizabeth E. Van Voorhees   +6 more
openalex   +2 more sources

Relation of the stress hyperglycaemia ratio to residual risk in anticoagulated patients with atrial fibrillation: A report from the prospective Murcia AF Project III cohort

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1431-1442, February 2026.
Abstract Introduction Atrial fibrillation (AF) carries residual thromboembolic and cardiovascular risk despite oral anticoagulation (OAC). The stress hyperglycaemia ratio (SHR), derived from admission glucose and glycated haemoglobin (HbA1c), integrates information on both acute glycaemic fluctuations and chronic glycaemic burden.
Eva Soler‐Espejo   +7 more
wiley   +1 more source

ECG Ambulatory System for Long Term Monitoring of Heart Rate Dynamics

open access: hybrid, 2011
Agustin Marquez-Espinoza   +3 more
openalex   +2 more sources

Classification of Stress via Ambulatory ECG and GSR Data [PDF]

open access: green, 2022
Zachary Dair   +4 more
openalex   +1 more source

Cardiovascular Challenges in Chronic Lymphocytic Leukemia (CLL) Patients Undergoing Bruton Tyrosine Kinase (BTK) Inhibitor Therapy

open access: yesEuropean Journal of Haematology, Volume 116, Issue 2, Page 104-115, February 2026.
ABSTRACT Background/Objectives Bruton tyrosine kinase inhibitors (BTKis) have revolutionized treatment for chronic lymphocytic leukemia (CLL), but cardiovascular (CV) toxicities pose significant challenges. Second‐generation BTKis offer improved target specificity, yet CV risks persist.
Stefano Oliva, Stefano Molica
wiley   +1 more source

Home - About - Disclaimer - Privacy